Large-scale preparation of UV-inactivated SARS coronavirus virions for vaccine antigen

Methods in Molecular Biology

Volumn 454, Issue , 2008, Pages 119-126

  Tsunetsugu Yokota, Yasuko ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Concentration of virions; Coronavirus; Plaque purification; SARS CoV; UV inactivation; Vaccine antigen; VERO E6 cells

Indexed keywords

CORONAVIRUS; SARS CORONAVIRUS;

EID: 84934437305     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-181-9_11     Document Type: Article

References (6)

1. Holmes, K.V. (2003) SARS coronavirus: a new challenge for prevention and therapy. J. Clin. Invest. 111, 1605-1609.
2. Peiris, J. S., Guan, Y., and Yuen, K. Y. (2004) Severe acute respiratory syndrome. Nature Med. 10, S88-97.
3. Tsunetsugu-Yokota, Y., Ohnishi, K., and Takemori, T. (2006) Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine. Rev. Med. Virol. 16, 117-131.
4. Takasuka, N., Fujii, H., Takahashi, Y., Kasai, M., Morikawa, S., Itamura, S., Ishii, K., Sakaguchi, M., Ohnishi, K., Ohshima, M., Hashimoto, S., Odagiri, T., Tashiro, M., Yoshikura, H., Takemori, T., and Tsunetsugu-Yokota, Y. (2004) A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice. Int. Immunol. 16, 1423-1430.
5. Ohnishi, K., Sakaguchi, M., Kaji, T., Akagawa, K., Taniyama, T., Kasai, M., Tsunetsugu-Yokota, Y., Oshima, M., Yamamoto, K., Takasuka, N., Hashimoto, S., Ato, M., Fujii, H., Takahashi, Y., Morikawa, S., Ishii, K., Sata, T., Takagi, H., Itamura, S., Odagiri, T., Miyamura, T., Kurane, I., Tashiro, M., Kurata, T., Yoshikura, H., and Takemori, T. (2005) Immunological detection of severe acute respiratory syndrome coronavirus by monoclonal antibodies. Jpn. J. Infect. Dis. 58, 88-94.
6. Tsunetsugu-Yokota, Y., Ato, M., Takahashi, Y., Hashimoto, S.-I., Kaji, T., Kuraoka, M., Yamamoto, K., Yamomoto, T., Ohshima, M., Ohnishi, K., and Takemori, T. (2007) Formalin-treated UV-inactivated SARS coronavirus vaccine retains its immunogenicity and promotes Th2-type immune responses. Jpn. J. Infect. Dis. 60, 106-112.